Article ID Journal Published Year Pages File Type
10745152 Parkinsonism & Related Disorders 2014 6 Pages PDF
Abstract
Our data suggest that trimethobenzamide helps reduce nausea/vomiting during the first 8 weeks of apomorphine therapy, but is generally not needed thereafter. Trimethobenzamide did not worsen parkinsonism nor affect “on” response after apomorphine injection.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
, , , ,